Management of Respiratory Acidosis

Initial Assessment and Oxygen Management

For patients with respiratory acidosis, the British Thoracic Society recommends immediately seeking senior review and initiating non-invasive ventilation if acidosis persists for more than 30 minutes after standard medical management, while maintaining controlled oxygen therapy with target saturations of 88-92% 1, 2
The British Thoracic Society suggests determining if the patient is critically ill and commencing 15 L/min oxygen via reservoir mask or bag-valve-mask immediately if critically ill, or proceeding with controlled oxygen therapy based on risk stratification if not critically ill 1, 3
The British Thoracic Society identifies patients at risk of hypercapnic respiratory failure, including those with moderate-to-severe COPD, severe chest wall or spinal disease, neuromuscular disease, severe obesity, cystic fibrosis, and bronchiectasis, and recommends targeting oxygen saturation at 88-92% while awaiting arterial blood gas results 1, 3, 4
The British Thoracic Society recommends initiating controlled oxygen therapy with 24% Venturi mask at 2-3 L/min, 28% Venturi mask at 4 L/min, or nasal cannulae at 1-2 L/min, and avoiding excessive oxygen use, as PaO₂ above 10.0 kPa increases the risk of respiratory acidosis in hypercapnic patients 1, 2, 4, 5

The British Thoracic Society recommends obtaining arterial blood gases immediately for all patients with suspected hypercapnic respiratory failure, and repeating ABGs after 30-60 minutes of oxygen therapy or sooner if clinical deterioration occurs 2, 4, 5, 6
The British Thoracic Society suggests interpreting ABG results algorithmically, including checking for respiratory acidosis (pH <7.35 and PCO₂ >6.0 kPa), chronic compensated hypercapnia (PCO₂ elevated but pH ≥7.35 with bicarbonate >28 mmol/L), and normal pH and PCO₂, and adjusting target saturation accordingly 1, 2, 3, 4, 5

The British Thoracic Society recommends initiating NIV if patient is hypercapnic (PCO₂ >6 kPa) and acidotic (pH <7.35) and respiratory acidosis persists for more than 30 minutes after initiation of standard medical management 2, 5
The British Thoracic Society suggests monitoring response to NIV, including rechecking ABGs after 1-2 hours and again after 4-6 hours if earlier sample showed little improvement, and discontinuing NIV and considering invasive ventilation if there is no improvement in PCO₂ and pH after 4-6 hours despite optimal ventilator settings 6, 7

The British Thoracic Society recommends targeting oxygen saturation at 88-92% for patients with neuromuscular and chest wall disorders, and measuring blood gases to determine if NIV will be required 2, 5
The British Thoracic Society suggests referring patients with respiratory failure due to neurological disorders, muscle disease, spinal cord lesions, or chest wall deformity for assessment to a center providing long-term ventilation at home 6, 7

A pH below 7.26 is predictive of poor outcome in COPD exacerbations, and a patient's pH of 7.0 places them in a life-threatening category requiring urgent escalation beyond standard medical therapy, according to the British Thoracic Society guidelines 8

The British Thoracic Society recommends nebulized bronchodilators be driven by compressed air (not oxygen) to avoid worsening hypercapnia in patients with COPD exacerbations 9, 10
If compressed air is unavailable, limit oxygen-driven nebulizers to 6 minutes and provide supplemental oxygen via nasal cannulae at 1-2 L/min during nebulization to minimize hypercapnia risk 11

High-concentration oxygen therapy can cause hypercapnia within 15 minutes in acute COPD, but controlled, titrated oxygen therapy targeting 88-92% SpO₂ can mitigate this risk, as recommended by the British Thoracic Society 9, 10
Step down oxygen to the lowest level maintaining SpO₂ 88-92% while initiating NIV if hypercapnia worsens, to avoid life-threatening rebound hypoxemia 11